SEH1L siliencing induces ferroptosis and suppresses hepatocellular carcinoma progression via ATF3/HMOX1/GPX4 axis
Authors:
Open Access
- 2 August 2024
- journal article
- research article
- Published by Springer Nature in Apoptosis
- Vol. 29 (9-10) , 1723-1737
Abstract
SEH1 like nucleoporin (SEH1L) is an important component of nuclear pore complex (NPC), which is crucial in the regulation of cell division. However, the interrelation between SEH1L expression and tumor progression is less studied. In this research, we performed a systematic bioinformatic analysis about SEH1L using TCGA, Timer 2.0, Cbioportal, UCLAN and CellMiner™ databases in pan-cancer. Besides, we further validated the bioinformatic results through in vitro and in vivo experiments in HCC, including transcriptome sequencing, real-time quantitative PCR (RT-qPCR), western blotting (WB), immunohistochemistry (IHC), cell proliferation assays, clone formation, EdU, transwell, flow cytometry and subcutaneous tumor model. Our results suggested that SEH1L was significantly up-regulated and related to poor prognosis in most cancers, and may serve as a potential biomarker. SEH1L could promote HCC progression in vitro and in vivo. Besides, the next generation sequencing suggested that 684 genes was significantly up-regulated and 678 genes was down-regulated after the knock down of SEH1L. SEH1L siliencing could activate ATF3/HMOX1/GPX4 axis, decrease mitochondrial membrane potential and GSH, but increase ROS and MDA, and these effects could be reversed by the knock down of ATF3. This study indicated that SEH1L siliencing could induce ferroptosis and suppresses hepatocellular carcinoma (HCC) progression via ATF3/HMOX1/GPX4 axis.Keywords
Funding Information
- Natural Science Foundation of Hunan Province (2024JJ6606, 2022JJ30895)
- Postdoctoral Fellowship Program of CPSF (GZC20233168)
- National Natural Science Foundation of China (82373049)
- Wisdom Gathering and Talent Cultivating Program from the Third Xiangya Hospital
This publication has 32 references indexed in Scilit:
- Blocking of FGFR4 signaling by F30 inhibits hepatocellular carcinoma cell proliferation through HMOX1-dependent ferroptosis pathwayEuropean Journal of Pharmacology, 2024
- Cu 2 WS 4 ‐PEG Nanozyme as Multifunctional Sensitizers for Enhancing Immuno‐Radiotherapy by Inducing FerroptosisSmall, 2024
- PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 ImmunotherapyAdvanced Science, 2023
- Nucleoporin Seh1 maintains Schwann cell homeostasis by regulating genome stability and necroptosisCell Reports, 2023
- The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinomaHepatology, 2023
- The spectrum of primary liver cancers: heterogeneity and continuity. A foundation for diagnosis and treatment of cancerHepatology, 2022
- Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progressionEBioMedicine, 2022
- EF24 induces ferroptosis in osteosarcoma cells through HMOX1Biomedicine & Pharmacotherapy, 2021
- A Pharmacogenomic Landscape in Human Liver CancersCancer Cell, 2019
- Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinomaJournal of Hepatology, 2012